In 2002, Pennsylvania state investigator Allen Jones discovered improprieties that lead to a succession of multi-billion dollar awards and settlements against Johnson & Johnson for fraudulent marketing of Risperdal. Before the recent spate of awards, the case that had arisen from Jones’ findings in Pennsylvania was dismissed. “I assisted the State of Texas in the recovery of $158 million dollars expended as the result of J&J’s fraudulent marketing of Risperdal,” said Jones, “Not only was Pennsylvania not interested in pursuing these facts, I was fired when I went public with allegations of corruption which were being covered up. (The state’s) … case was so weak it was rightfully thrown out of court.” Judges in Pennsylvania’s Commonwealth Court are set to hear an appeal of the 2008 dismissal.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.